{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:56:02Z","timestamp":1789764962535,"version":"4.0.1"},"reference-count":82,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>From the beginning of the pandemic, people with cancer have experienced a high burden from COVID-19 compared with the general population, both in terms of severe COVID-19-related outcomes and reduced health-related quality of life and mental health. This review presents and discusses expert views on the burden of COVID-19 in individuals with cancer throughout the pandemic. The literature suggests that early in the pandemic, people with cancer had a disproportionately high risk of COVID-19-related hospitalization compared with the general population. This trend continued throughout the pandemic, even after the availability of vaccinations (including boosters) and the emergence of less virulent strains. Rates of hospitalization, intensive care unit admission, and mechanical ventilation varied across studies but were all seen to be higher in people with cancer and COVID-19 compared with the general population or those with cancer alone. Moreover, studies indicated worsened quality of life and mental health in these people during the pandemic and lockdown periods compared with prepandemic or postlockdown periods. Although COVID-19 has entered the endemic phase and is no longer a global health emergency, it remains a significant risk for people with cancer. Generally, COVID-19 continues to increase healthcare resource use, impair mental health, and reduce quality of life in this population, highlighting the need for continued real-world studies. Ongoing research is essential to evaluate the impact of COVID-19 on vaccinated people with cancer, particularly those undergoing systemic cancer therapy who may require continued guidance on preventive measures and treatments to mitigate the risk of severe COVID-19.<\/jats:p>","DOI":"10.1093\/oncolo\/oyaf074","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T19:07:20Z","timestamp":1750964840000},"source":"Crossref","is-referenced-by-count":4,"title":["COVID-19 burden of illness in people who are immunocompromised due to cancer: an expert opinion review"],"prefix":"10.1093","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6175-4277","authenticated-orcid":false,"given":"Igor","family":"Aurer","sequence":"first","affiliation":[{"name":"University Hospital Centre Zagreb , 10000 Zagreb ,","place":["Croatia"]},{"name":"Department of Internal Medicine, Medical School, University of Zagreb , 10000 Zagreb ,","place":["Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Moss","sequence":"additional","affiliation":[{"name":"College of Medicine and Health, University of Birmingham , Birmingham, B15 2TT ,","place":["UK"]},{"name":"University Hospitals Birmingham, NHS Foundation Trust , Birmingham, B15 2GW ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Goldman","sequence":"additional","affiliation":[{"name":"I3h Institute, Universit\u00e9 Libre de Bruxelles , Bruxelles 1050 ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Tuthill","sequence":"additional","affiliation":[{"name":"University of Oxford, Manor Hospital\/Genesis Care , Oxford, OX4 6LB ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Einsele","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, W\u00fcrzburg University Hospital , W\u00fcrzburg 97080 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Casa\u00f1as i Comabella","sequence":"additional","affiliation":[{"name":"EVIDERA, Evidence, Value and Access by PPD, Granta Park Great Abington , Cambridge, CB21 6GQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"James","sequence":"additional","affiliation":[{"name":"EVIDERA, Evidence, Value and Access by PPD , Paris, 94853 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Borkowska","sequence":"additional","affiliation":[{"name":"EVIDERA, Evidence, Value and Access by PPD , Warsaw, 02-672 ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fungwe","family":"Jah","sequence":"additional","affiliation":[{"name":"Medical Affairs, BioPharmaceuticals Medical, AstraZeneca , Hamburg, 22763 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabada","family":"Dube","sequence":"additional","affiliation":[{"name":"Vaccines and Immune Therapies Unit, AstraZeneca , Cambridge, CB2 0AA ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Klein","sequence":"additional","affiliation":[{"name":"Medical Affairs, BioPharmaceuticals Medical, AstraZeneca , Groot-Bijgaarden, 1702 ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Kandeil","sequence":"additional","affiliation":[{"name":"Vaccines and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca , Baar, 6340 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Yokota","sequence":"additional","affiliation":[{"name":"P95 Epidemiology & Pharmacovigilance , Leuven, 3000 ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pagliuca","sequence":"additional","affiliation":[{"name":"Stem Cell Transplantation, King\u2019s College London\/King\u2019s College Hospital , London, SE5 9RS ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0141-4753","authenticated-orcid":false,"given":"Gkikas","family":"Magiorkinis","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian, University of Athens , Athens 115 72 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Arnetorp","sequence":"additional","affiliation":[{"name":"Health Economics & Payer Evidence, Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca , Gothenburg, 431 50 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennard","family":"Lee","sequence":"additional","affiliation":[{"name":"Centre for Immuno-oncology, Nuffield Department of Medicine, University of Oxford , Oxford, OX3 7DQ ,","place":["UK"]},{"name":"Institute of Cancer and Genomic Sciences, University of Birmingham , Birmingham, B15 2TT ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"2025062615071176100_CIT0001","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.ccell.2020.09.018","article-title":"COVID-19 and cancer: current challenges and perspectives","volume":"38","author":"Bakouny","year":"2020","journal-title":"Cancer Cell"},{"key":"2025062615071176100_CIT0002","doi-asserted-by":"publisher","first-page":"100747","DOI":"10.1016\/j.lanepe.2023.100747","article-title":"Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study","volume":"35","author":"Evans","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"2025062615071176100_CIT0003","doi-asserted-by":"publisher","first-page":"519","DOI":"10.20892\/j.issn.2095-3941.2020.0289","article-title":"COVID-19 in cancer patients: risk, clinical features, and management","volume":"17","author":"Liu","year":"2020","journal-title":"Cancer Biol Med"},{"key":"2025062615071176100_CIT0004","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s12288-021-01472-3","article-title":"Outcomes of COVID-19 in hematopoietic stem cell transplant recipients: multicenter retrospective analysis","volume":"38","author":"Agrawal","year":"2022","journal-title":"Indian J Hematol Blood Transfus"},{"key":"2025062615071176100_CIT0005","doi-asserted-by":"publisher","first-page":"e603","DOI":"10.1097\/HS9.0000000000000603","article-title":"COVID-19 in patients receiving CD20-depleting immunochemotherapy for B-cell lymphoma","volume":"5","author":"Gaitzsch","year":"2021","journal-title":"Hemasphere"},{"key":"2025062615071176100_CIT0006","doi-asserted-by":"publisher","first-page":"100549","DOI":"10.1016\/j.eclinm.2020.100549","article-title":"Determinants of outcome in Covid-19 hospitalized patients with lymphoma: a retrospective multicentric cohort study","volume":"27","author":"Lamure","year":"2020","journal-title":"EClinicalMedicine"},{"key":"2025062615071176100_CIT0007","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S1470-2045(22)00273-X","article-title":"Outcomes of the SARS-CoV-2 Omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study","volume":"23","author":"Pinato","year":"2022","journal-title":"Lancet Oncol"},{"key":"2025062615071176100_CIT0008","doi-asserted-by":"publisher","first-page":"100350","DOI":"10.1016\/j.puhip.2022.100350","article-title":"Differences in case-fatality-rate of emerging SARS-CoV-2 variants","volume":"5","author":"Liu","year":"2023","journal-title":"Public Health Pract (Oxf)"},{"key":"2025062615071176100_CIT0009","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12916-022-02422-0","article-title":"Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY","volume":"20","author":"Open","year":"2022","journal-title":"BMC Med"},{"key":"2025062615071176100_CIT0010","doi-asserted-by":"publisher","first-page":"22278733","DOI":"10.1101\/2022.08.13.22278733","article-title":"QCovid 4 - Predicting risk of death or hospitalisation from COVID-19 in adults testing positive for SARS-CoV-2 infection during the Omicron wave in England","author":"Hippisley-Cox","year":"2022","journal-title":"medRxiv"},{"key":"2025062615071176100_CIT0011","doi-asserted-by":"publisher","first-page":"Pkaa120","DOI":"10.1093\/jncics\/pkaa120","article-title":"Rates of COVID-19-related outcomes in cancer compared with noncancer patients","volume":"5","author":"Sun","year":"2021","journal-title":"JNCI Cancer Spectr"},{"key":"2025062615071176100_CIT0012","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000523872","article-title":"COVID-19 in patients with hematologic malignancies: clinical manifestations, persistence, and immune response","volume":"145","author":"Gur","year":"2022","journal-title":"Acta Haematol"},{"key":"2025062615071176100_CIT0013","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejca.2021.02.011","article-title":"Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors","volume":"148","author":"Rogado","year":"2021","journal-title":"Eur J Cancer"},{"key":"2025062615071176100_CIT0014","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1056\/NEJMc2031670","article-title":"Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer","volume":"383","author":"Aydillo","year":"2020","journal-title":"N Engl J Med"},{"key":"2025062615071176100_CIT0015","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/QCO.0000000000000841","article-title":"Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside","volume":"35","author":"Laracy","year":"2022","journal-title":"Curr Opin Infect Dis"},{"key":"2025062615071176100_CIT0016","doi-asserted-by":"publisher","first-page":"ofad306","DOI":"10.1093\/ofid\/ofad306","article-title":"Successful treatment of persistent symptomatic coronavirus disease 19 infection with extended-duration nirmatrelvir-ritonavir among outpatients with hematologic cancer","volume":"10","author":"Liu","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2025062615071176100_CIT0017","doi-asserted-by":"publisher","first-page":"100285","DOI":"10.1016\/j.ctarc.2020.100285","article-title":"Cancer patients and COVID-19: mortality, serious complications, biomarkers, and ways forward","volume":"26","author":"Gupta","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"2025062615071176100_CIT0018","doi-asserted-by":"publisher","first-page":"286170","DOI":"10.1155\/2014\/286170","article-title":"Selective depletion of regulatory T cell subsets by docetaxel treatment in patients with nonsmall cell lung cancer","volume":"2014","author":"Li","year":"2014","journal-title":"J Immunol Res"},{"key":"2025062615071176100_CIT0019","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1470-2045(09)70069-5","article-title":"Nosocomial infections in patients with cancer","volume":"10","author":"Kamboj","year":"2009","journal-title":"Lancet Oncol"},{"key":"2025062615071176100_CIT0020","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jaut.2017.07.010","article-title":"Myeloid suppressor cells in cancer and autoimmunity","volume":"85","author":"Sica","year":"2017","journal-title":"J Autoimmun"},{"key":"2025062615071176100_CIT0021","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.cmi.2021.09.036","article-title":"Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review","volume":"28","author":"Galmiche","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2025062615071176100_CIT0022","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1001\/jamaoncol.2022.5974","article-title":"Association of SARS-CoV-2 spike protein antibody vaccine response with infection severity in patients with cancer: a national COVID cancer cross-sectional evaluation","volume":"9","author":"Lee","year":"2023","journal-title":"JAMA Oncol"},{"key":"2025062615071176100_CIT0023","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s00277-023-05204-7","article-title":"Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma","volume":"102","author":"Ishio","year":"2023","journal-title":"Ann Hematol"},{"key":"2025062615071176100_CIT0024","doi-asserted-by":"publisher","first-page":"e068632","DOI":"10.1136\/bmj-2021-068632","article-title":"Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis","volume":"376","author":"Lee","year":"2022","journal-title":"BMJ"},{"key":"2025062615071176100_CIT0025","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/S2213-2600(22)00170-9","article-title":"Immunocompromise and durability of BNT162b2 vaccine against severe outcomes due to omicron and delta variants","volume":"10","author":"Tartof","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2025062615071176100_CIT0026","doi-asserted-by":"publisher","first-page":"100198","DOI":"10.1016\/j.lana.2022.100198","article-title":"Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: a retrospective cohort study","volume":"9","author":"Tartof","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"2025062615071176100_CIT0027","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.3390\/vaccines10091474","article-title":"Assessment of postvaccination neutralizing antibodies response against SARS-CoV-2 in cancer patients under treatment with targeted agents","volume":"10","author":"Zagouri","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"2025062615071176100_CIT0028","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1470-2045(21)00715-4","article-title":"Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer","volume":"23","author":"Ligumsky","year":"2022","journal-title":"Lancet Oncol"},{"key":"2025062615071176100_CIT0029","author":"Cancer.Net"},{"key":"2025062615071176100_CIT0030","doi-asserted-by":"publisher","first-page":"S322","DOI":"10.1016\/j.jval.2023.03.1841","article-title":"PCR62 Post-lockdown behaviors and impacts of avoiding COVID-19 in individuals and caregivers of individuals at high-risk of severe COVID-19: a qualitative study","volume":"26","author":"Maia","year":"2023","journal-title":"Value Health"},{"key":"2025062615071176100_CIT0031","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s13187-023-02312-w","article-title":"Cancer screening and treatment delays during the COVID-19 pandemic and the role of health literacy in care re-engagement: findings from an NCI-designated comprehensive cancer center sample","volume":"38","author":"Keim-Malpass","year":"2023","journal-title":"J Cancer Educ"},{"key":"2025062615071176100_CIT0032","doi-asserted-by":"publisher","first-page":"5875","DOI":"10.2147\/CMAR.S318115","article-title":"Cancer services during the COVID-19 pandemic: systematic review of patient\u2019s and caregiver\u2019s experiences","volume":"13","author":"Dhada","year":"2021","journal-title":"Cancer Manag Res"},{"key":"2025062615071176100_CIT0033","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1200\/GO.20.00639","article-title":"Delays and disruptions in cancer health care due to COVID-19 pandemic: systematic review","volume":"7","author":"Riera","year":"2021","journal-title":"JCO Glob Oncol"},{"key":"2025062615071176100_CIT0034","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/biology12040545","article-title":"COVID-19 in adult patients with hematological malignancies-lessons learned after three years of pandemic","volume":"12","author":"Hus","year":"2023","journal-title":"Biology (Basel)"},{"key":"2025062615071176100_CIT0035","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1002\/pon.5946","article-title":"Psychological distress of cancer patients caused by treatment delay during the COVID-19 pandemic in China: a cross-sectional study","volume":"31","author":"Ye","year":"2022","journal-title":"Psychooncology"},{"key":"2025062615071176100_CIT0036","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/S0140-6736(22)01656-7","article-title":"Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales","volume":"400","author":"Agrawal","year":"2022","journal-title":"Lancet"},{"key":"2025062615071176100_CIT0037","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1182\/blood.2020008824","article-title":"Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients","volume":"136","author":"Vijenthira","year":"2020","journal-title":"Blood"},{"key":"2025062615071176100_CIT0038","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1002\/cncr.33832","article-title":"Higher severity and risk of in-hospital mortality for COVID-19 patients with cancer during the year 2020 in Brazil: a countrywide analysis of secondary data","volume":"127","author":"Costa","year":"2021","journal-title":"Cancer"},{"key":"2025062615071176100_CIT0039","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1080\/03007995.2023.2233819","article-title":"Assessing the risk and costs of COVID-19 in immunocompromised populations in a large United States commercial insurance health plan: the EPOCH-US Study","volume":"39","author":"Ketkar","year":"2023","journal-title":"Curr Med Res Opin"},{"key":"2025062615071176100_CIT0040","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/jamaoncol.2020.6178","article-title":"Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection","volume":"7","author":"Wang","year":"2021","journal-title":"JAMA Oncol"},{"key":"2025062615071176100_CIT0041","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/ijc.33846","article-title":"Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: a population-based multistate cohort study including 4 618 377 adults in Catalonia, Spain","volume":"150","author":"Roel","year":"2022","journal-title":"Int J Cancer"},{"key":"2025062615071176100_CIT0042","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/03008916211073771","article-title":"Outcomes of SARS-CoV-2 infection in cancer versus non-cancer-patients: a population-based study in northeastern Italy","volume":"109","author":"Rugge","year":"2023","journal-title":"Tumori"},{"key":"2025062615071176100_CIT0043","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/jnci\/djaa159","article-title":"Prevalence and outcome of COVID-19 infection in cancer patients: a National Veterans Affairs study","volume":"113","author":"Fillmore","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"2025062615071176100_CIT0044","doi-asserted-by":"publisher","first-page":"1758835920971147","DOI":"10.1177\/1758835920971147","article-title":"COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study","volume":"12","author":"Crolley","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"2025062615071176100_CIT0045","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejca.2020.09.035","article-title":"Risk factors for coronavirus disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: a French nationwide cohort study (GCO-002 CACOVID-19)","volume":"141","author":"Li\u00e8vre","year":"2020","journal-title":"Eur J Cancer"},{"key":"2025062615071176100_CIT0046","doi-asserted-by":"publisher","first-page":"7781","DOI":"10.1002\/cam4.4271","article-title":"Prevalence, determinants, and outcomes of SARS-COV-2 infection among cancer patients. A population-based study in northern Italy","volume":"10","author":"Serraino","year":"2021","journal-title":"Cancer Med"},{"key":"2025062615071176100_CIT0047","doi-asserted-by":"publisher","first-page":"20406223211047755","DOI":"10.1177\/20406223211047755","article-title":"Prognostic factors in cancer patients infected with SARS-CoV-2: a Latin American country results","volume":"12","author":"Ruiz-Garcia","year":"2021","journal-title":"Ther Adv Chronic Dis"},{"key":"2025062615071176100_CIT0048","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.7150\/jca.79969","article-title":"Impact of vaccination against COVID-19 on patients with cancer in ACHOC-C19 study: real world evidence from one Latin American country","volume":"14","author":"Ospina","year":"2023","journal-title":"J Cancer"},{"key":"2025062615071176100_CIT0049","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13045-022-01333-0","article-title":"Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL","volume":"15","author":"Antic","year":"2022","journal-title":"J Hematol Oncol"},{"key":"2025062615071176100_CIT0050","doi-asserted-by":"publisher","first-page":"100445","DOI":"10.1016\/j.lana.2023.100445","article-title":"Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium","volume":"19","author":"Choueiri","year":"2023","journal-title":"Lancet Reg Health Am"},{"key":"2025062615071176100_CIT0051","doi-asserted-by":"publisher","first-page":"100781","DOI":"10.1016\/j.xcrm.2022.100781","article-title":"Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer","volume":"3","author":"Fendler","year":"2022","journal-title":"Cell Rep Med"},{"key":"2025062615071176100_CIT0052","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.3390\/v14112377","article-title":"Patients with hematological malignancies treated with T-cell or B-cell immunotherapy remain at high risk of severe forms of COVID-19 in the Omicron era","volume":"14","author":"Zerbit","year":"2022","journal-title":"Viruses"},{"key":"2025062615071176100_CIT0053","doi-asserted-by":"publisher","first-page":"100441","DOI":"10.1016\/j.lanepe.2022.100441","article-title":"Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: a cohort study of 28 million people in France","volume":"19","author":"Semenzato","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"2025062615071176100_CIT0054","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/03008916211022848","article-title":"Fears, beliefs, and quality of life of patients with cancer vs the general population during the coronavirus disease 2019 (COVID-19) pandemic in Lombardy","volume":"108","author":"Ripamonti","year":"2022","journal-title":"Tumori"},{"key":"2025062615071176100_CIT0055","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1080\/0284186x.2021.1902565","article-title":"Health-related quality of life of patients with haematologic cancer during COVID-19 and their opinions on telehealth consultations\u2013a Danish single site cross-sectional survey","volume":"60","author":"Ellehuus","year":"2021","journal-title":"Acta Oncol"},{"key":"2025062615071176100_CIT0056","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.2147\/CMAR.S370034","article-title":"Quality of life and its associated factors among cancer patients receiving chemotherapy at oncology hospitals in Vietnam after the third wave of the COVID-19 pandemic","volume":"14","author":"Nguyen","year":"2022","journal-title":"Cancer Manag Res"},{"key":"2025062615071176100_CIT0057","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/0284186X.2020.1830169","article-title":"Quality of life in patients with cancer during the COVID-19 pandemic \u2013 a Danish cross-sectional study (COPICADS)","volume":"60","author":"Jeppesen","year":"2021","journal-title":"Acta Oncol"},{"key":"2025062615071176100_CIT0058","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.3390\/ijerph19063731","article-title":"Quality of life in patients with pancreatic cancer before and during the COVID-19 pandemic","volume":"19","author":"Alexander","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2025062615071176100_CIT0059","doi-asserted-by":"publisher","first-page":"S246","DOI":"10.1016\/j.jval.2021.11.1199","article-title":"POSC374 association of COVID-19 on adherence to oral specialty pharmacy oncology medications and quality of life of multiple myeloma patients","volume":"25","author":"Burruss","year":"2022","journal-title":"Value Health"},{"key":"2025062615071176100_CIT0060","doi-asserted-by":"publisher","first-page":"102311","DOI":"10.1016\/j.jogoh.2022.102311","article-title":"The psychological impact of therapeutic changes during the COVID-19-lockdown for gynaecological and breast cancer patients","volume":"51","author":"Lamblin","year":"2022","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"2025062615071176100_CIT0061","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1007\/s00520-021-06789-3","article-title":"Anxiety and depression in patients with advanced cancer during the COVID-19 pandemic","volume":"30","author":"Obispo-Portero","year":"2022","journal-title":"Support Care Cancer"},{"key":"2025062615071176100_CIT0062","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/onco.13962","article-title":"Clinical impact of the COVID-19 pandemic in Mexican patients with thoracic malignancies","volume":"26","author":"Arrieta","year":"2021","journal-title":"Oncologist"},{"key":"2025062615071176100_CIT0063","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.3390\/cancers14071794","article-title":"The psychological distress of cancer patients following the COVID-19 pandemic first lockdown: results from a large French survey","volume":"14","author":"Marino","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025062615071176100_CIT0064","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.eprac.2022.01.002","article-title":"Anxiety during the COVID-19 pandemic: a web-based survey of thyroid cancer survivors","volume":"28","author":"Graves","year":"2022","journal-title":"Endocr Pract"},{"key":"2025062615071176100_CIT0065","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.sleh.2022.04.005","article-title":"Prevalence and factors associated with insomnia symptoms in adolescents and young adults with cancer during the COVID-19 pandemic","volume":"8","author":"Tulk","year":"2022","journal-title":"Sleep Health"},{"key":"2025062615071176100_CIT0066","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1007\/s00520-021-06628-5","article-title":"Loneliness among adolescents and young adults with cancer during the COVID-19 pandemic: a cross-sectional survey","volume":"30","author":"Howden","year":"2022","journal-title":"Support Care Cancer"},{"key":"2025062615071176100_CIT0067","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.clindermatol.2021.11.014","article-title":"Self-reported measure of subjective distress in response to COVID-19 pandemic in patients referred to our skin cancer unit during the first wave","volume":"40","author":"Borsari","year":"2022","journal-title":"Clin Dermatol"},{"key":"2025062615071176100_CIT0068","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/pon.5849","article-title":"Psychological distress and experiences of adolescents and young adults with cancer during the COVID-19 pandemic: a cross-sectional survey","volume":"31","author":"Glidden","year":"2022","journal-title":"Psychooncology"},{"key":"2025062615071176100_CIT0069","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jpainsymman.2023.06.028","article-title":"Postvaccine era COVID-19 pandemic-related distress in palliative care patients with advanced cancer","volume":"66","author":"Shih","year":"2023","journal-title":"J Pain Symptom Manage"},{"key":"2025062615071176100_CIT0070","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00432-022-03961-y","article-title":"Attitudes toward a COVID-19 vaccine and vaccination status in cancer patients: a cross-sectional survey","volume":"148","author":"Heyne","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"2025062615071176100_CIT0071","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12904-022-01034-y","article-title":"Psychological distress and resilience in patients with advanced cancer during the Covid-19 pandemic: the mediating role of spirituality","volume":"21","author":"Mihic-Gongora","year":"2022","journal-title":"BMC Palliative Care"},{"key":"2025062615071176100_CIT0072","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40359-023-01126-1","article-title":"A study of COVID anxiety, spiritual well-being and resilience levels in patients with cancer undergoing chemotherapy during the COVID-19 pandemic: a cross-sectional study in the south of Iran","volume":"11","author":"Khiyali","year":"2023","journal-title":"BMC Psychol"},{"key":"2025062615071176100_CIT0073","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/26350106231153073","article-title":"Influence of diabetes mellitus on oncological outcomes for patients living with cancer","volume":"49","author":"Murphy","year":"2023","journal-title":"Sci Diabetes Self Manag Care"},{"key":"2025062615071176100_CIT0074","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s11764-015-0486-3","article-title":"The impact of having both cancer and diabetes on patient-reported outcomes: a systematic review and directions for future research","volume":"10","author":"Vissers","year":"2016","journal-title":"J Cancer Surviv"},{"key":"2025062615071176100_CIT0075","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2337\/dc11-1313","article-title":"Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival","volume":"35","author":"Currie","year":"2012","journal-title":"Diabetes Care"},{"key":"2025062615071176100_CIT0076","doi-asserted-by":"publisher","first-page":"e000968","DOI":"10.1136\/esmoopen-2020-000968","article-title":"Influenza in hospitalised patients with malignancy: a propensity score matching analysis","volume":"5","author":"Li","year":"2020","journal-title":"ESMO Open"},{"key":"2025062615071176100_CIT0077","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/irv.12704","article-title":"Influenza in patients with cancer after 2009 pandemic AH1N1: an 8-year follow-up study in Mexico","volume":"14","author":"Angeles-Sistac","year":"2020","journal-title":"Influenza Other Respir Viruses"},{"key":"2025062615071176100_CIT0078","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/pbc.21472","article-title":"Influenza-associated morbidity in children with cancer","volume":"50","author":"Tasian","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"2025062615071176100_CIT0079","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s15010-022-01852-5","article-title":"Mortality in cancer patients with SARS-CoV-2 or seasonal influenza: an observational cohort study from a German-wide hospital network","volume":"51","author":"Kodde","year":"2023","journal-title":"Infection"},{"key":"2025062615071176100_CIT0080","author":"Bernardi"},{"key":"2025062615071176100_CIT0081","doi-asserted-by":"publisher","first-page":"e0295597","DOI":"10.1371\/journal.pone.0295597","article-title":"Factors influencing COVID-19 mortality among cancer patients: a Brazilian multi-institutional study","volume":"18","author":"da Silva","year":"2023","journal-title":"PLoS One"},{"key":"2025062615071176100_CIT0082","doi-asserted-by":"publisher","first-page":"22269053","DOI":"10.1101\/2022.01.11.22269053","article-title":"Post-traumatic stress symptoms in cancer patients during the COVID-19 pandemic: a one-year longitudinal study","author":"Bastien","year":"2022","journal-title":"medRxiv"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/30\/6\/oyaf074\/63504864\/oyaf074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/30\/6\/oyaf074\/63504864\/oyaf074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T19:07:20Z","timestamp":1750964840000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/doi\/10.1093\/oncolo\/oyaf074\/8164539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,4]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyaf074","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,6]]},"article-number":"oyaf074"}}